REGIMED MEDICAL

Regimed Medical specializes in the manufacturing of sterile pharmaceutical preparations and in-vitro diagnostic substances under strict cGMP standards, serving the operational needs of federal healthcare systems. The company produces a range of oral solid dosage forms—including ferrous sulfate, naltrexone, and fexofenadine tablets—as well as multi-line pharmaceutical kits for centralized military and veteran care facilities. Their technical expertise lies in formulation development, batch consistency, packaging compliance, and supply chain integrity for high-volume, low-margin critical medications used in VA and HHS treatment protocols. Regimed’s ability to rapidly scale production of niche therapeutics and maintain stringent FDA and DEA regulatory alignment positions them as a reliable source for mission-critical pharmaceuticals in time-sensitive, high-reliability environments. The contractor maintains a consistent and deep relationship with the Department of Veterans Affairs, supplying essential medications to Community-Based Outpatient Clinics and Centralized Manufacturing Operations across multiple geographic regions. Their work supports the VA’s National Formulary and CMOP network by delivering precisely specified, lab-tested pharmaceuticals tailored to veteran health needs. A single contract with the Department of Health and Human Services indicates potential involvement in public health diagnostic support, though the VA remains their dominant and enduring partner. Regimed Medical operates under NAICS 325412 for pharmaceutical preparation manufacturing and 325413 for in-vitro diagnostic substance production, focusing exclusively on the federal medical supply chain. They are not a distributor or wholesaler but a manufacturer of active pharmaceutical ingredients and finished dosage forms, serving the unique demands of government healthcare procurement with precision and regulatory rigor. As a 2J entity based in Saint Peters, Missouri, Regimed Medical is a small business with no federal certifications on record. Their geographic footprint is centered on federal medical logistics hubs, enabling efficient distribution to VA and HHS facilities nationwide. The company’s market positioning is defined by reliability, regulatory compliance, and niche manufacturing agility within the federal pharmaceutical ecosystem.